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Objectives:Aortic Customize is a new concept for endo-
vascular aortic aneurysm repair in which a nonpolymerised
elastomer is injected to fill the aneurysm sac around a balloon-
catheter. Aim of this in-vitro study was to investigate the
extent of aneurysm wall stress reduction by the presence of an
elastomer cuff.
Methods: A latex aneurysm (inner radius sac 18mm,
inner radius neck 8mm), equipped with 12 tantalummarkers,
was attached to an in-vitro circulation model. Fluoroscopic
roentgenographic stereo photogrammetric analysis (FRSA)
was used to measure marker movement during 6 cardiac
cycles. The radius of 3 circles drawn through the markers was
measured before and after sac-filling. Wall movement was
measured at different systemic pressures. Wall-stress was cal-
culated from the measured radius (
  pr/2t).
Results: The calculated wall-stress was 7.5-15.6 N/cm2
before sac-filling and was diminished to 0.43-1.1 N/cm2
after sac-filling. Before sac-filling there was a clear increase
(p  0, 001) in radius of the proximal (range 7.9% - 33.5%),
middle (range 3.3% - 25.2%) and distal (range 10.5% -
184.3%) rings with increasing systemic pressure. After sac-
filling with the elastomer there remained a small, significant
(p 0, 001), increase in the radius of the circles (ranges 6.8% -
8.8%; 0.7% - 1.1%; 5.3% - 6.7%). The sac-filling reduced the
extent of radius increase. The treated aneurysm withstood
pressures up to 220/140 mm Hg without noticeable wall-
movement.
Conclusions: Filling the aneurysm sac with a biocom-
patible elastomer leads to successful exclusion of the aneu-
rysm sac from the circulation. Wall-movement and calcu-
lated wall stress are diminished noticeably by the injection
of biocompatible elastomer.
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Objectives: Endovascular repair (EVAR) of infrarenal
aortic aneurysms (AAA) is increasingly utilized in patients
with suitable aortic morphology. Despite improvements in
graft design, type II endoleak (EL-2) either from theinferior mesenteric artery (EL-IMA) or lumbar artery (EL-
LA) remains the Achilles’ heel of EVAR. The objective of
this study is to evaluate AAA sac diameter in patients with
and without EL-2. Our hypothesis is: persistent EL-2 is
associated with inferior sac regression.
Methods: Retrospective analysis of all nonruptured AAA
treated by elective EVAR using FDA-approved endografts
from January 2005 to December 2008 at Mercy Medical
Center, Des Moines, IA was performed. Review of medical
records, preoperative and follow-upCT angiograms (CTA) at
1 and 6 months were performed. Patients with type I, III and
IV endoleak were excluded. Change in AAA sac diameter at 6
months was compared in patients: 1) with and without EL-2;
2) with occluded vs patent IMA.
Results: The study cohort comprised of 198 patients (165
men, 33 women, mean age 74 years). Mean preoperative AAA
diameter was 5.5 cm (range 4-11 cm). EL-2 was present in 27%
at completion of EVAR and persisted in 9% at amean follow-up
of 6 months (range 4-8 months). 94% of EL-LA resolved on
follow-up vs 55%ofEL-IMA(p0.01, Fisher exact test).Mean
change in sac diameter at 6 months was 0.04 cm in patients
with EL-2 vs0.48 cm in patients without EL-2 (p 0.002, t
test). Preoperatively, the IMA was occluded by coils or chroni-
cally occluded in 92 patients vs 105 patients who had a patent
IMA. At 6months, mean change in sac diameter was0.06 cm
in patients with a patent IMA vs 0.57 cm in patients with an
occluded IMA (p 0.001, t test).
Conclusions: Persistent EL-2 following EVARoccurred
in 9% of patients, predominantly from the IMA. 55% of
EL-IMA did not resolve and lead to increase in sac diameter.
Occlusion of the IMA led to greater sac shrinkage following
EVAR and should be considered when the IMA is widely
patent.
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Objectives: To examine the mortality and morbidity of
Crawford type IV thoracoabdominal aortic aneurysm (TAAA)
repair at a single university hospital over 10 years.
Methods: All patients undergoing open type IV TAAA
repair between 1998 and 2008 were prospectively entered
into a database (n 108). Repairs were performed through
a left retroperitoneal incision.
